Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HAO vs GXC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HAO Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 7–1 Matrix Metrics)

HAO Overall Winner 6-Pillar Tally: HAO 4 – 0 GXC (2 Tie) Matrix Metrics: HAO 7 – 1 GXC

As of Nov 16, 2026, Haoxi Health Technology Limited Class A (HAO) is the stronger overall head-to-head candidate over SPDR S&P China ETF (GXC) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). HAO carries a Unified Composite Score of 55.9/100 (HOLD) at $2.00 (N/M Forward P/E, -14.9% operating margin), whereas GXC carries 39.5/100 (SELL) at $80.19 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: HAO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.2); meanwhile GXC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HAO vs GXC
HAO NASDAQ Head-to-Head Winner
Haoxi Health Technology Limited Class A Ordinary Shares
Services-Advertising Agencies
$2.00
-4.09% 1D
Market Cap $1.3M
TTM Revenue $55M
Forward P/E N/M
Beta / 30D Vol 7.50β · 151% Vol
Unified Composite Score
55.9 / 100 HOLD
Tech 70.0 Fund 45.0 Flow 50.0 Mom 58.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 47.2 · SMA20: $1.96 · SMA50: $2.39
GXC NYSE Arca
SPDR S&P China ETF
Institutional Equity
$80.19
-1.14% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.65β · 20% Vol
Unified Composite Score
39.5 / 100 SELL
Tech 34.0 Fund 50.0 Flow 50.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.9%), weak momentum, RSI 33
RSI-14: 33.3 · SMA20: $82.28 · SMA50: $84.96

6-Pillar Scorecard Institutional Category Breakdown (HAO 4 – 0 GXC)

Columns: Metric · HAO · GXC
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale HAO
Revenue Growth (YoY) +137.3% N/A
Earnings Growth (YoY) +172.7% N/A
TTM Revenue (USD) $55M N/A
Market Cap $1.3M N/A
3. Profitability & Quality HAO
Gross Margin 1.1% N/A
Operating Margin -14.9% N/A
Net Profit Margin -17.4% N/A
Return on Equity (ROE) -54.1% N/A
4. Balance Sheet & Cash Flow HAO
Cash Generation (TTM) -$7.9M EBITDA N/A
Cash Flow Margin -14.3% EBITDA Mgn N/A
Net Cash / Leverage $160.71 Book/Sh · -54.1% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 30.8% (8th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat HAO
OpEx & R&D Intensity 16.0% of Rev ($8.8M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Advertising Agencies Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HAO (7) vs GXC (1)
Institutional Metric HAO GXC Criterion Row Edge
Market Capitalization
Scale
$1.3M N/A Larger Scale HAO
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+137.3% N/A Higher Growth HAO
Operating Margin (TTM)
Profitability
-14.9% N/A Higher Margin HAO
Net Profit Margin
Profitability
-17.4% N/A Higher Margin HAO
Return on Equity (ROE)
Capital Efficiency
-54.1% N/A Higher ROE HAO
52-Week Range Position
Momentum
36% ($0–$5) 0% ($80–$105) Stronger Trend HAO
Beta / 30D Volatility
Risk Regime
7.50β · 151% Vol 0.65β · 20% Vol Lower Realized Risk GXC
Unified Institutional Score
Composite Signal
55.9 / 100 (HOLD) 39.5 / 100 (SELL) Higher Composite HAO
Trailing 12M Revenue (USD)
Operating Scale
$55M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
1.1% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.9M EBITDA ($160.71 Book/Sh · -54.1% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GXC +0.87 pp
HAO: -5.45% · GXC: -4.58%
3M Horizon GXC +43.81 pp
HAO: -55.57% · GXC: -11.76%
6M Horizon HAO +11123.1 pp
HAO: +11107.87% · GXC: -15.23%
1Y Horizon HAO +142.18 pp
HAO: +119.96% · GXC: -22.22%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HAO vs GXC. Trailing 12-month operating profitability (HAO -14.9% vs GXC N/A) and valuation multiples (HAO N/M vs GXC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

HAO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$55M
Gross Margin1.1%
Op. Margin-14.9%
ROE / Fwd P/E-54.1% · N/M
GXC ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HAO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HAO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GXC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.8%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GXC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HAO Moat Profile Cyclical / Execution-Driven Positioning
Advertising Agencies Operator
Competes within the Advertising Agencies value chain with $1.3M market capitalization and -14.9% operating margin.
OpEx & R&D Reinvestment 16.0% of Rev ($8.8M)
90D Engineering Disclosures 0 Published
GXC Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ HAO vs GXC Key Questions & Quantitative Answers

As of Nov 16, 2026, Haoxi Health Technology Limited Class A (HAO) is the stronger overall head-to-head candidate over SPDR S&P China ETF (GXC) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). HAO carries a Unified Composite Score of 55.9/100 (HOLD) at $2.00 (N/M Forward P/E, -14.9% operating margin), whereas GXC carries 39.5/100 (SELL) at $80.19 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: HAO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.2); meanwhile GXC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HAO leads the Growth & Scale pillar: HAO posts +137.3% YoY revenue growth and +172.7% YoY earnings growth on $55M TTM revenue (1.1% gross margin, -14.9% operating margin), compared with GXC at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, HAO generates $55M in USD-normalized revenue versus N/A for GXC. In operating R&D and SG&A reinvestment, HAO deploys 16.0% of Rev ($8.8M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GXC.

HAO and GXC trade at balanced relative valuation multiples. HAO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-14.3% EBITDA margin), whereas GXC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HAO (-54.1% ROE) versus GXC (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, HAO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (7.50β · 151% Vol realized risk). By comparison, GXC carries 30.8% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.65β · 20% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.